CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed
Drug / intervention
cyclosporine +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00000524
NCT00000524Phase 2Completed
CompareCT.gov

Myocarditis Treatment Trial

University of Utah·interventional·Posted Oct 28, 1999·Updated Apr 18, 2023

In Brief

A Phase 2 clinical trial evaluating cyclosporine and prednisone for Cardiovascular Diseases and 2 related conditions. Completed.

Detailed Summary

To determine whether immunosuppressive treatment improved cardiac function in patients with biopsy-proven myocarditis.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCardiovascular Diseases, Heart Diseases, Myocarditis
Countries--
CollaboratorsNational Heart, Lung, and Blood Institute (NHLBI)

Timeline

Phase 2CompletedFinished
198619871988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedOct 28, 1999
Enrollment StartJul 1, 1986
Study CompletionMar 1, 1994
TodayJul 2, 2026
Posted 26.7 years ago

Interventions

cyclosporinedrug

prednisonedrug